Comment on: current opinions on the management of prolonged ischemic priapism: does penoscrotal decompression outperform corporoglanular tunneling?

Omer A. Raheem,Marwan Alkassis,Rosemary Iwuala

DOI: https://doi.org/10.1038/s41443-024-00876-9

2024-03-21

International Journal of Impotence Research

Abstract:Appropriate treatment for ischemic priapism is not only time-sensitive, but equally challenging in prolonged presentation. In this article, VanDyke et. al. performed a survey of sexual medicine and genitourinary reconstructive urologists to gauge expert opinions on whether penoscrotal decompression (PSD) outperforms corporoglanular tunneling (CGT) in the setting of prolonged ischemic priapism (PIP). The study authors define PIP as starting 24 h after onset of ischemic priapism [1]. Bennett and Mulhall showed that all of patients who undergo successful decompression within 12 h from onset recover complete erectile function but this decreases to 78% between 12 and 24 h, and to 44% between 24 and 36 h from onset. Beyond 36 h, erectile dysfunction could be inevitable due to the accumulation of fibrosis of cavernosal smooth muscle [2]. Several advocates are proposing clearer practice guidelines for treatment of PIP with the ultimate objective to salvaging erectile function in PIP. Non-invasive interventions for acute ischemic priapism, including aspiration of the corpora and intracavernosal injections of alpha-adrenergic medications, are insufficient for treating PIP [3]. More traditionally surgical interventions, including distal and proximal corporal shunts are often performed, but these have also been shown to be ineffective in the treatment of PIP, especially in patients who have experienced recurrent priapism [3]. Tunneling maneuvers, namely CGT and PSD are more effective at resolving PIP and reducing recurrent priapism. CGT was introduced in 2009 as a surgical modification on the Al-Ghorab distal shunt and showed promising results in achieving decompression [4]. PSD is a new method outlined by Fuchs et al. in 2018 that capitalizes on the well-established technique used to insert a malleable penile prosthetic that dilates the corpora with a penoscrotal approach [5]. It also avoids disruption of the distal corpora which is helpful in case penile prosthesis would need to be placed eventually to treat resultant medically-refactorry erectile dysfunction [5].

urology & nephrology